Overview
Global Hemostats Market reached US$ XX million in 2023 and is expected to reach US$ XX million by 2031, growing at a CAGR of XX% during the forecast period 2024-2031
A hemostat is a surgical tool to control bleeding by clamping exposed blood vessels shut. It is similar to pliers and scissors and is part of a group of pivoting instruments that determine its function. The hemostat’s locking mechanism, consisting of interlocking teeth, allows the user to adjust the clamping force of the pliers. Hemostats are often used in the first stages of surgery to line incisions on blood vessels awaiting ligation.
Market Dynamics: Drivers & Restraints
Rise in the number of surgical procedures
The hemostats market growth is driven by the rise in chronic diseases like spinal problems, cardiovascular diseases, cancer, accidents, and trauma. Hemostats play a crucial role in blood control during surgical procedures, as they are used in 60-70% of transfused red blood cells. In 2020, the U.S. had 1,806,590 new cancer cases.
The demand for hemostat products in surgical procedures is increasing due to the minimal risk of blood loss, their lower infection risk, and their cost-effectiveness. The increase in surgeries is expected to boost the revenue of the hemostats market, as surgeons increasingly choose these products for their minimal risk of blood loss.
Furthermore, the global hemostats market are also driven by various other factors like a rise in the advancements of devices, a rise in healthcare infrastructure and others helping the market to grow during the forecast period.
Limited access in developing regions
Thermostat agents and devices are vital in modern healthcare, but their availability is limited in underserved and developing regions due to inadequate healthcare infrastructure. This affects the availability of surgical services and necessary tools, including hemostatic products. In these areas, limited facilities and resources make it difficult for patients to access necessary surgical care.
For more details on this report – Request for Sample

Segment Analysis
The global hemostats market is segmented based on product type, application, end-user and region.
The halstead mosquito hemostatic forceps from the product type segment accounted for approximately 39.3% of the hemostats market share
The halstead mosquito hemostatic forceps from the product type segment accounted for approximately 39.3%. Halsted (or Halstead) Mosquito Forceps, also called mosquito hemostatic forceps or simply hemostats, are surgical instruments designed for clamping blood vessels or other small tissues to control bleeding during surgery or to provide a secure grip. They are so named because they resemble the slender legs of a mosquito. Life science researchers like these fine hemostats because of their secure grip and the ability to manipulate them in confined spaces.

Geographical Analysis
North America is estimated to hold about 38.4% of the total market share throughout the forecast period
North America is estimated to hold about 38.4% of the total market share throughout the forecast period owing to factors like the novel product launches by key players, advancements in the forceps, rise in the prevalence of chronic diseases, rise in the number of surgical procedures and others help the region to have highest market share during the forecast period.
For instance, according to the Organization for Economic Co-Operation and Development in 2021, they were 3,83,717 surgical procedures were performed in Canada. Hence the demand for the surgical hemostat’s forceps increases simultaneously which helps the region and market to grow during the forecast period.
Covid 19 Impact Analysis
The impact of COVID-19 on hemostats has been significant where hospitals and healthcare facilities have faced surges in patient volumes due to COVID-19. This increased demand for medical equipment, including hemostats and forceps, especially in settings such as intensive care units (ICUs) and emergency departments where these instruments are commonly used.
Market Segmentation
By Product type

  • Halstead mosquito hemostatic forceps
  • Helly and Crile hemostatic forceps
  • Rochester-carmalt hemostatic forceps
  • Others


By Application

  • Cardiovascular surgery
  • General surgery
  • Gynecological surgery
  • Reconstructive surgery
  • Neurological surgery
  • Orthopedic surgery
  • Others


By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others


By Region

  • North America


o U.S.
o Canada
o Mexico

  • Europe


o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe

  • South America


o Brazil
o Argentina
o Rest of South America

  • Asia-Pacific


o China
o India
o Japan
o South Korea
o Rest of Asia-Pacific

  • Middle East and Africa



Competitive Landscape
The major global players in the market include Integralife Lifesciences, Artivion, Medesy, World Precision Instruments, Agnthos, GerMed USA, Burtons Veterinary, Prodent USA, Thermo Fisher Scientific Inc, Bausch & Lomb Incorporated among others.
Why Purchase the Report?

  • To visualize the global hemostats market segmentation based on product type, application, end user and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analysing trends and co-development.
  • Excel data sheet with numerous data points of the hemostats market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.


The global hemostats market report would provide approximately 64 tables, 61 figures and 186 pages.
Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies